Evidence-Based Complementary and Alternative Medicine

Therapies of Traditional Chinese Medicine for Cardiovascular Diseases


Publishing date
01 Jan 2021
Status
Closed
Submission deadline
28 Aug 2020

Lead Editor

1North China University of Science and Technology, Tangshan, China

2Beijing University of Chinese Medicine, Beijing, China

3Henan University of Chinese Medicine, Zhengzhou, China

4Tianjin University of Chinese Medicine, Tianjin, China

5Hong Kong Polytechnic University, Hong Kong

6Mayo Clinic, Rochester, USA

This issue is now closed for submissions.

Therapies of Traditional Chinese Medicine for Cardiovascular Diseases

This issue is now closed for submissions.

Description

Cardiovascular diseases (CVDs), including coronary heart disease, cerebrovascular disease, and heart failure, are the leading cause of death worldwide. In 2016, an estimated 17.9 million people died from CVDs, accounting for 31% of all global deaths. Recent reports on CVDs in China indicate that the prevalence and mortality of CVDs are still on the rise. The estimated number of people suffering from CVDs in China alone is 290 million, and the death rate of CVDs still ranks as first, accounting for more than 40% of deaths across the population. In recent years, the death rate of CVDs in rural areas has been shown to be higher than that in urban areas. The total cost of hospitalization for CVDs is also increasing rapidly, with the annual growth rate much higher than the GDP growth rate. The increasing burden of CVDs has become a major public health problem, and as such, there is an urgent need to prevent and treat CVDs.

Although some recent reviews have suggested that Traditional Chinese Medicine (TCM) may benefit some heart disease patients and TCM treatment of diseases has indeed been recognized by patients, there is a lack of evidence-based research in line with the requirements of modern medical science. The exact mechanisms of the actions of TCM also need to be explained by scientific data, and so expert attention is needed to support the clinical value and effectiveness of TCM in treating CVDs.

The aim of this Special Issue is to collate results from the following aspects including the safety of TCM therapies, side effects, clinical trials, and practice, to enrich the current knowledge of the efficacy of TCM therapies in treating CVDs. We invite researchers to contribute original research articles as well as review articles that will assess the roles of TCM therapies for CVDs.

Potential topics include but are not limited to the following:

  • In vivo or in vitro study to explore the exact mechanism of TCM therapies for CVDs
  • Recent development in TCM therapies for CVDs
  • Randomized clinical trials of TCM therapies for CVDs
  • Systematic review and/or meta-analysis of TCM therapies for CVDs
  • Toxicological effects associated with the use of TCM therapies for CVDs
  • Clinical practice of TCM therapies with conventional medicines and western medicine for CVDs
  • Perspective or commentary articles on TCM therapies for CVDs

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 9473531
  • - Research Article

Research on Effect and Mechanism of Xuefu Zhuyu Decoction on CHD Based on Meta-Analysis and Network Pharmacology

Fuguang Kui | Wenwen Gu | ... | Gangjun Du
  • Special Issue
  • - Volume 2021
  • - Article ID 8616413
  • - Research Article

The Clinical Efficacy of Phytochemical Medicines Containing Tanshinol and Ligustrazine in the Treatment of Stable Angina: A Systematic Review and Meta-Analysis

Li Gao | Tong Wu | ... | Wei Wang
  • Special Issue
  • - Volume 2020
  • - Article ID 8870148
  • - Review Article

Gastrodia elata Blume (Tianma): Hope for Brain Aging and Dementia

Klaus Heese
  • Special Issue
  • - Volume 2020
  • - Article ID 9413724
  • - Research Article

Suppressive Effects of the Gynura bicolor Ether Extract on Endothelial Permeability and Leukocyte Transmigration in Human Endothelial Cells Induced by TNF-α

Shu-Ling Hsieh | Jyh-Jye Wang | ... | Chih-Chung Wu
  • Special Issue
  • - Volume 2020
  • - Article ID 5471931
  • - Research Article

Traditional Chinese Medicine for Essential Hypertension: A Clinical Evidence Map

Yan Zhang | Biqing Wang | ... | Fengqin Xu
  • Special Issue
  • - Volume 2020
  • - Article ID 8881683
  • - Research Article

Literature-Based Drug Repurposing in Traditional Chinese Medicine: Reduced Inflammatory M1 Macrophage Polarization by Jisil Haebaek Gyeji-Tang Alleviates Cardiovascular Disease In Vitro and Ex Vivo

Ga-Ram Yu | Seung-Jun Lee | ... | Jai-Eun Kim
  • Special Issue
  • - Volume 2020
  • - Article ID 6131525
  • - Review Article

Xinmailong Injection for Improvement of Cardiac Function in Patients with Heart Failure: A Systematic Review and Meta-Analysis

Yuan-long Sun | Yi-ping Li | ... | Xiao-long Wang
  • Special Issue
  • - Volume 2020
  • - Article ID 5067137
  • - Research Article

The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease

Cailan Li | Qian Li | ... | Xiaobo Yang
  • Special Issue
  • - Volume 2020
  • - Article ID 8539148
  • - Research Article

Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats

Miaomiao Liu | Yurun Xue | ... | Li Chu
  • Special Issue
  • - Volume 2020
  • - Article ID 5790275
  • - Research Article

Electroacupuncture Inhibits Atherosclerosis through Regulating Intestinal Flora and Host Metabolites in Rabbit

Yuping Shen | Ze-Dong Cheng | ... | Rui Wang
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.